Adverse drug reactions linked to Ciwujia injection: A systematic review of 521 cases

Journal of Evidence-Based Medicine

Volumn 3, Issue 1, 2010, Pages 37-43

  Hu, Jing ^a   Shang, Hongcai ^a   Li, Jing ^a   Zhang, Li ^a   Zhang, Junhua ^a   Zheng, Wenke ^a   Li, Tingqian ^b   Zhang, Boli ^a   Li, Youping ^b  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

ADR reports; Adverse drug reactions; Ciwujia injection; Clinical studies

Indexed keywords

CHINESE DRUG;

ALLERGIC ASTHMA; ALLERGY; ANAPHYLACTIC SHOCK; CHINESE MEDICINE; CONSTIPATION; COUGHING; DEMOGRAPHY; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; EDEMA; FATIGUE; FEVER; HEADACHE; HUMAN; INJECTION SITE PAIN; LETHARGY; MEDICAL INFORMATION; MELENA; NAUSEA AND VOMITING; PRIORITY JOURNAL; REVIEW; STOMACH PAIN; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CHINA; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; YOUNG ADULT;

EID: 77954589338     PISSN: 17565383     EISSN: 17565391     Source Type: Journal    
DOI: 10.1111/j.1756-5391.2010.01066.x     Document Type: Review

References (64)

1. Wu LJ, Ruan LJ. Studies on chemical constituents from acanthopanax senticosus (rupr.et maxim.) harms. Acta Pharmaceutica Sinica 1999; 34(11): 839-841.
2. Lei ZQ. Clinical Chinese Materia Medica of China. 1st edition. Beijing: People's Medical Publishing House, 1998: 1629.
3. Chen XQ. Materia Medica Newly Edited. 16th edition. Beijing: People's Medical Publishing House, 2007: 802.
4. Fan LJ, Jiang XH, Yao GE. Study progression of Ciwujia injection. Chinese Traditional Patent Medicine 2003; 25(6): 488-490.
5. Li HL, Li XH, Ma KR. Clinical application of Ciwujia injection. Lishizhen Medicine and Materia Medical Research 2005; 16(6): 542-543.
6. Zhao HB. Efficacy of Ciwujia injection for 20 cerebral thrombosis patients. Journal of Gansu College of Traditional Chinese Medicine 1988; 1: 27-28.
7. Zhou J, Wu XY, Lin YH, et al. Analysis of 5165 ADRs cases. Chinese Journal of Drug Application and Monitoring 2004; 1(1): 45-47.
8. Zhang QW, Sun XF. Death from anaphylactic shock induced by Ciwujia injection. Adverse Drug Reactions Journal 2007; 9(1): 57.
9. Zhu BH, Hu M. Three anaphylactic reactions caused by Ciwujia injection. Journal of Chinese Rural Physician 1998; 10: 45-46.
10. Chi XH. A Case of Acanthopanax Root Allergic Reaction Induced Death. Shanxi Nursing Journal 2003; 17(1): 67.
11. Lu XB, Li XH, Zhao FL. Two severe anaphylactic reactions caused by Ciwujia injection. Journal of Emergency in Traditional Chinese Medicine 2006; 15(10): 1166-1167.
12. Jing SX, Sheng YQ. Two anaphylactic reactions caused by Ciwujia injection. Heilongjiang Medicine and Pharmacy 1993; 16(4): 77.
13. Zhan SY. The urgency and specificity of study on pharmacoepidemiology. Chinese Journal of Epidemiology 2001; 22(6): 403-404.
14. Zhou CF, Xu ZL, Lin YH. Attention should be paid to the postmarketing reevaluation of traditional Chinese medicine injection. Chinese Journal of Pharmacovigilance 2006; 3(5): 129.
15. OuYang R, Liao JP, Hu TL, et al. Investigation on stability of compatibility of Ciwujia Injection and five other drugs. Chinese Journal of Information on TCM 2000; 7(12): 48-49.
16. Xu YH, Song YC, Zhang LY. Change after compatibility of Ciwujia injection and fourteen drugs in four liquor. Chinese Traditional and Herbal Drugs. 1998; 29(4): 239-240.
17. Tian ZG, Yu JX, Sun JY. One Allergy caused by compatibility of Ciwujia injection and Fufang Danshen injection. Modern Journal of Integrated Traditional Chinese and Western Medicine 2004; 13(16): 2176.
18. Zhang LM, Song C, Zhang X. Stability of compatibility of Ofloxacin injection and drugs commonly used. Chinese Remedies and Clinics 2005; 5(10): 770-772.
19. Zhou YW, Zhang DK, Ling JiG, Wu C. Compatibility of shuanghuanglian injection ith 13 drugs. Northwest Pharmaceutical Journal 1997; 12(6): 257-258.
20. Zhang JS, Xiang GC. The incompatibility of Shuanghuanglian injection powder in clinical use. Journal of Regional Anatomy and Operative Surgery 2001; 10(4): 411.
21. Shi FH, Zhao TY, Zheng QY. The Changes of Shuanghuanglian after mixed with seven injections. Heilongjiang Medical Journal 1996; 9(2): 70-71.
22. Zhang FX, Chai AJ, Hou YN, Liu HC. The compatibility of Shuanghuanglian and Qingkailing injection with five kinds of Quinolones. Herald of Medicine 2002; 21(5): 313-314.
23. Li F, Zhang ZT, Wu RQ, Xu SQ. Study of plasma drug concentration of ampicillin and Shuanghuanglian on compatible. Chinese Journal of Modern Applied Pharmcy 1999; 16(1): 60-62.
24. Wang AJ, Yang GD. The observation of Ribavirin injection combined with 6 kinds of antibiotics and Shuanghuanglian. Northwest Pharmaceutical Journal 1995; 10(1): 35-36.
25. Tang P, Lin CH. Analysis the compatibility of dopamine with 5 kinds of drugs. Guangxi Medical Journal 2000; 22(5): 1060-1061.
26. Li ZM. The changes of Shuanghuanglian injection combined with Metronidazole injection. Journal of Jiangxi College of Traditional Chinese Medicine 1996; 8(s1): 50-51
27. Chen YM, Zou JH, Jiang KY. The changes of insoluble particles of Shuanghuanglian mixed with penicillin in the four kinds of fluids before and after compatibility. Jiangsu Pharmaceutical and Clinical Research 2001; 9(2): 56-57.
28. Li JK, Geng HK, Duan SY, et al. Study on compatibility of penicillin G with Chinese herbal medicine Injection. China Pharmacist 2001; 4(2): 138-139.
29. Ye YQ, Ma NH, Liu ZY. The Study of the phenomenon after traditional Chinese medicine injection combined with ciprofloxacin lactate injection 1999; 31(11): 36-37.
30. Wang G, Li DF. Investigation on the stability of cefotaxime sodium combined with several injections. China Pharmaceuticals 2000; 9(10): 35-36.
31. Fan SQ, Jia DB, Li F, et al. The stability experiment of aminophylline injection combined with Shuanghuanglian. Monthly Publication of Medicine 1992; 11(9): 26-28.
32. Fang Y, Chen LM, Dai M, et al. The interaction of pharmacokinetic in rabbit after Shuanghuanglian powder for injection mixed with cefazolin. Chinese Pharmaceutical Journal 2006; 41(18): 1411-1414.
33. Li ZK, Yu CB, Peng Y, et al. Research on the stability of compatible of Shuanghuanglian injection powder with cefazolin sodium injection. Primary Journal of Chinese Materia Medica 2002; 16(1): 21-22.
34. Wang H, Wu DY, Du ZM. Effects on CYP2D6 of the single use of Ampicillin or Shuanghuanglian and combination. Herald of Medicine 2008; 27(5): 491-494.
35. Yu QK, Kan SY, Yang JC, et al. The stability compatibility of levofloxacin injection with anti-inflammatory traditional Chinese medical injection. Chinese Journal of Hospital Pharmacy 2007; 27(1): 120-121.
36. Zhu YM, Li SM, Wu XD, et al. Compatible stability of fleroxacin injection after mixing with anti-infection traditional medicine injection. Chinese Journal of Clinical Pharmacy 2004; 13(2): 90-93.
37. Du ZM, Zhu B, Zhang B. In vitro bacteriostasis and the compatible stability of Shuanghuanglian injection combined with penicillin sodium. Journal of Harbin Medical University 2003; 37(4): 330-332.
38. Chen HQ, Yao MK, Fang YY. The investigation of stability of Pefloxacin injection combined with 20 drugs. Strait Pharmaceutical Journal 2000; 12(2): 12-13.
39. Ye AJ, Zhang XM. The investigation of stability of Shuanghuangliang injection combined with fosfomycin sodium. Strait Pharmaceutical Journal 1999; 11(3): 19-20.
40. Ma WC, Tao LC. Shuanghuangliang injection powder is not suitable to combined with Vitamin C. Journal of Zhejiang College of TCM 2000; 24(5): 67-8.
41. Ma WC, Tao LC. Shuanghuangliang injection powder is not suitable to combined with Vitamin C. Journal of Zhejiang College of TCM 2000; 24(5): 67-8. 41. Huang YY, Chen ZH. The investigation of stability of Shuanghuangliang injection powder combined with Vit C. Acta Academiae Medicinae Suzhou 1999; 19(3): 273.
42. Li GX, Liu JX. Three cases of hypersensitization associated with Shuanghuangliang injection combined with benzylpenicillin. Journal of Handan Medical College 2001; 14(2): 117.
43. Yang WJ, Fei YY. One case of ADR associated with Shuanghuangliang injection combined with benzylpenicillin. Journal of Practical Medical Techniques 2000; 7(5): 376.
44. Yuan W, Jin XY. Three hypersensitization reports about Shuanghuangliang injection combined with other drugs in Clinic. Shanghai Medical & Pharmaceutical Journal 1995; 17(10): 20.
45. Sun CF. Several point should be observed when use Shuanghuangliang injection. Shandong Journal Traditional Chinese Medicine 2000; 19(11): 666.
46. Yu AR, Tian HY, Fan YQ. The incompatibility of Shuanghuanglian with Amikacin injection. Journal of Linyi Medical College 1997; 19(3): 202.
47. Chi FY, Wang YX, Zhang KH. Incompatibility of Shuanghuanglian injection with Amikacin. Journal of Medcal Radiological Technology 2005; 1(233): 17.
48. Liu Y, Lv P. Incompatibility of Shuanghuanglian with amikacin injection. Chinese Journal of Rural Medicine and Pharmacy 1999; 6(7): 22.
49. Song XH, Zhao XH. Incompatibility of Shuanghuanglian injection with aminoglycosides. China Journal of Clinical Medicine 2002; 3(7): 53.
50. Zhang YY, Yang JH. Incompatibility of Shuanghuanglian injection with gentamycin. Yunan Journal of Traditional Chinese Medicine and Materia Medica 2004; 25(1): 50.
51. Zhu HP. Incompatibility of Shuanghuanglian injection with gentamycin sulfate injection. China's Naturopathy 2003; 11(10): 45.
52. Li YL. Incompatibility of Shuanghuanglian injection powder with aminoglycosides. Anthology of Medicine 1999; 18(4): 624.
53. Yang SJ, Ma DY. Report of crystallization at the interface of Shuanghuanglian and tobramycin. China Journal of Chinese Materia Medica 2003; 28(1): 92-93.
54. Ge RQ, Jin BT. Incompatibility of Shuanghuanglian injection with tobramycin. Qianwei Journa of Medicine 1999; 16(5): 274.
55. Li HY. The advertent problem of Shuanghuanglian injection combined with netilmicin. Journal of Qilu Nursing 2005; 11(4): 347.
56. Li WC, Wu WQ. One case analysis of incompatibility of Shuanghuanglian injection with netilmicin sulfate and glucose injection. Chinese Journal of Modern Nursing Journal 2004; 1(2): 74-75.
57. Zhang LW, Lin HP. Shuanghuanglian injection is incompatibility with lincomycin. Heilongjiang Nursing Journal 2005; 11(8): 602.
58. Wang EG, Lian L, Li L. One case report of anaphylactoid purpura due to Shuanghuanglian injection combined with amono benzylpenicillin. Chinese Journal of Modern Applied Pharmacy 1993; 10(2): 57.
59. Yang DH, Gao J. One case report of ADR due to Shuanghuanglian injection combined with ciprofloxacin lactate. Shanxi Nursing Journal 1995; 9(5): 226.
60. Huang CG, Lv LP. Research on the compatibility of Fleroxacin with Fufangdanshen, Chuanhuning, and Shuanghuanglian injections. China Journal of Medicine 2004; 3(5): 51-52.
61. Chen ZM, Zhao J, Zhang Y, et al. Clinical observation of interaction in the tubing when phentolamine combined withcommon Chinese medicines. Medical Journal of National Defending Forces in Southwest China 2006; 16(3): 311.
62. Lv EX. Shuanghuanglian injection can not compatibility with Vit B6. Theory and Practice of Medicine 2006; 19(6): 686.
63. Lu AN. Shuanghuanglian injection (freeze-dry) can not compatibility with Etimicin. Heilongjiang Nursing Journal 2007; 13(2): 176.
64. Li HM, Zhao LJ. Problem and resolutions of Chinese medicine mixed with western medical injections. Journal of China Practical Medical 2007; 7(4): 321-323.